VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SBCWWSBC Medical Group Holdings Incorporated
$0.19$19M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSBCWWP/E History

SBCWW logoSBC Medical Group Holdings Incorporated (SBCWW) P/E Ratio History

Deep Value

Trading at 0.4x · 14th percentile of 5-year range · Significant discount to historical valuation · Data 2024–2026

Current P/E (TTM)
0.4x
-45% vs 5Y avg
5Y Avg P/E
0.7x
Median 0.6x
5Y Percentile
14th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
0.4x
Min0.4xMedian0.6xMax1.1x
TTM EPS$0.40
Price$0.19
Earnings Yield100.00%
EPS Growth (1Y)4.2%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, SBC Medical Group Holdings Incorporated (SBCWW) trades at a price-to-earnings ratio of 0.4x, with a stock price of $0.19 and trailing twelve-month earnings per share of $0.40.

The current P/E is 45% below its 5-year average of 0.7x. Over the past five years, SBCWW's P/E has ranged from a low of 0.4x to a high of 1.1x, placing the current valuation at the 14th percentile of its historical range.

Compared to the Industrials sector median P/E of 25.6x, SBCWW trades at a 99% discount to its sector peers. The sector includes 403 companies with P/E ratios ranging from 0.1x to 198.8x.

Relative to the broader market, SBCWW trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SBCWW DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

SBCWW Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Industrials
0.4vs25.6
-99%
Below Sector
vs. S&P 500
0.4vs24.4
-98%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 4% EPS growth (1Y)

SBCWW P/E vs Peers

Operations and human capital consulting peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
INMD logoINMDInMode Ltd.
$849M9.4Lowest0.94Best-36%
EW logoEWEdwards Lifesciences Corporation
$50B47.76.74-74%
ISRG logoISRGIntuitive Surgical, Inc.
$144B51.72.37+23%Best
SYK logoSYKStryker Corporation
$118B36.62.46+8%
HOLX logoHOLXHologic, Inc.
$17B30.5--25%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

SBCWW Historical P/E Data (2024–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q1-$0.30$0.390.8x+11%
FY2025 Q4Dec 31 2025$0.21$0.490.4x-39%
FY2025 Q3-$0.21$0.420.5x-27%
FY2025 Q2Jun 30 2025$0.19$0.330.6x-14%
FY2025 Q1Mar 31 2025$0.19$0.500.4x-46%
FY2024 Q4-$0.24$0.241.0x+47%
FY2024 Q3Sep 30 2024$0.15$0.131.1x+67%

Average P/E for displayed period: 0.7x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

2+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SBCWW — Frequently Asked Questions

Quick answers to the most common questions about buying SBCWW stock.

What is SBCWW's P/E ratio?

SBC Medical Group Holdings Incorporated (SBCWW) trailing twelve-month P/E ratio is 0.4x, based on TTM diluted EPS of $0.40. The 5-year average P/E is 0.7x and the historical range spans 0.4x to 1.1x.

Is SBCWW stock overvalued or undervalued?

SBCWW trades at 0.4x P/E, below its 5-year average of 0.7x. At the 14th percentile of its historical range (0.4x–1.1x), the stock is priced at a discount to its own history.

Is SBCWW stock expensive?

No, SBCWW is not expensive on a historical basis. The current P/E of 0.4x is below the 5-year average of 0.7x and sits at the 14th percentile of its valuation range.

What is SBCWW's historical P/E range?

Over the past 5 years, SBCWW's P/E ratio has ranged from 0.4x to 1.1x, with a median of 0.6x and an average of 0.7x. The current P/E of 0.4x places the stock at the 14th percentile of this range. Full historical data spans 2024–2026.

How does SBCWW's P/E compare to the S&P 500?

SBCWW trades at 0.4x P/E versus the S&P 500 median of 24.4x. The 98% discount to the market suggests lower growth expectations or perceived higher risk.

How does SBCWW's valuation compare to Industrials peers?

SBC Medical Group Holdings Incorporated P/E of 0.4x compares to the Industrials sector median of 25.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is SBCWW's PEG ratio?

SBCWW PEG ratio is N/A, based on a P/E of 0.4x and EPS growth of 4.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is SBCWW's earnings yield?

SBCWW earnings yield is 100.00%, the inverse of its 0.4x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

SBCWW P/E Ratio History (2024–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current0.8x
Period Avg0.7x
Range0.4x - 1.1x
Change-33%
7 quartersSep 30, 2024 - Mar 31, 2026